Market Close Report, 14 August 2026: Sensex, Nifty Slip as Asian Paints Drags

Today at a glance

Today, 14 August 2026: Nifty 50 closed at 24,366.00, down 69.90 points (-0.29%), marking a negative session. Consumer and state banking stocks led the decline as Asian Paints faced selling pressure amid high wholesale inflation prints. APOLLOHOSP was the top gainer; ASIANPAINT the top loser. For SIP investors, periodic index dips offer disciplined rupee-cost averaging opportunities to accumulate mutual fund units at favorable valuations.

What happened in the markets today

On Friday, 14 August 2026, the Sensex today closed at 78,009.25, up 42.85 points or 0.05%, while the Nifty 50 declined 69.90 points to settle at 24,366.00. Macro commodities were subdued, with gold easing -0.15% to $4,413.60 and silver holding flat at $65.00 (+0.01%). Meanwhile, crude oil futures rose +0.71% to $81.83 per barrel, and the USD/INR currency pair settled slightly firmer at 95.42 (-0.02%). Why did Nifty 50 fall today? Profit-taking in Asian Paints and State Bank of India weighed on benchmark indices despite gains in healthcare and telecom shares.

Movers: Healthcare and Telecom gain, Consumer and Banking drag Nifty 50

Today’s Nifty 50 gainers were Apollo Hospitals, Bharti Airtel, and Adani Ports.

Today’s Nifty 50 losers were Asian Paints, Oil and Natural Gas Corporation, and State Bank of India.

Healthcare flagship Apollo Hospitals and telecom leader Bharti Airtel provided strong defensive support, whereas pullbacks in Asian Paints and State Bank of India capped broader market upside.

In the news

• WPI Inflation Eases Marginally to 9.78% in July as Food and Fuel Cool — India’s wholesale price index (WPI) inflation moderated slightly to 9.78% in July 2026, driven by cooling price pressures across food articles, manufactured products, and domestic fuel tariffs. While the sequential dip offers mild relief to input cost burdens for manufacturers, overall wholesale inflation prints remain elevated relative to historical baseline ranges. Economists expect the Reserve Bank of India to maintain a vigilant policy stance to ensure price stability before considering any rate easing measures. [Source: The Hindu]

• U.S. FDA Issues Warning Letter to Aurobindo Pharma Subsidiary Eugia Pharma — The United States Food and Drug Administration has issued a formal warning letter to Eugia Pharma Specialities, a wholly-owned subsidiary of domestic pharmaceutical manufacturer Aurobindo Pharma. The regulatory communication follows an inspection of the company’s injectable manufacturing facility and cites compliance deviations in sterile manufacturing protocols. Market analysts note that remediation timelines and potential delays in product approvals could impact near-term export revenue trajectories until regulatory clearance is achieved. [Source: The Hindu]

• Stock Markets Decline in Early Trade as Benchmark Indices Encounter Headwinds — Domestic equity benchmarks opened on a hesitant note during morning trade, with the Sensex dropping over 300 points during initial trading hours amid cautious global market cues. Institutional investors maintained a measured approach, rotating capital out of cyclical banking names and into defensive healthcare counters. Market strategists noted that while early intra-session volatility tested investor resolve, domestic mutual fund inflows continued to offer structural support at lower price levels. [Source: The Hindu]

• Bombay High Court Directs Lending Institutions and Vijay Mallya to Resolve Long-Standing Dispute — The Bombay High Court has urged commercial banks and former aviation entrepreneur Vijay Mallya to explore an amicable settlement regarding decades-old non-performing loan recoveries. The judicial bench emphasized that prolonged litigation across multiple jurisdictions consumes institutional resources without expediting capital recovery for public sector lenders. Legal experts highlight that a structured recovery resolution could strengthen bank balance sheet recoveries and streamline ongoing debt settlement procedures. [Source: The Hindu]

• Inflation Trajectory Demands Sustained Vigilance Amid Global Commodity Swings — Macroeconomic editorial assessments highlight that despite recent marginal moderation in headline numbers, persistent inflation across core service baskets continues to warrant monetary caution. Global crude oil volatility and currency cross-currents present ongoing upside risks to domestic retail price trajectories. Analysts emphasize that preserving purchasing power requires structural policy coordination alongside steady household allocation toward inflation-beating asset classes. [Source: The Hindu]

What it means for SIP investors

When macroeconomic headlines spotlight elevated wholesale inflation and single-stock pullbacks in blue-chip shares like Asian Paints and SBI, systematic investment plan (SIP) investors frequently question their portfolio durability. Staying committed to automated monthly contributions shields your portfolio from the pitfalls of market timing. To preserve your long-term wealth against rising prices, understanding how inflation affects your SIP returns helps you set realistic real-return expectations and optimize target corpus calculations.

Temporary index consolidation allows regular monthly installments to accumulate fund units at lower average costs. If short-term market turbulence makes you second-guess your investment horizon, reviewing why you should continue SIP during market crashes reinforces the disciplined compounding mindset needed to achieve multi-decade financial milestones.

Returns snapshot — 1-day & long-term

1-Day Returns:

Long-Term Returns (20-Year CAGR):

Over multi-decade investment horizons, Indian benchmark equity indices have compounded at robust double-digit rates through varying economic cycles. With the Sensex today holding firm at 78,009.25, maintaining disciplined automated SIP investments remains the most reliable pathway toward long-term wealth creation.